Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

In this study, polydioxanone threads significantly reduced hair loss and promoted hair regrowth in patients with androgenetic alopecia who did not respond to minoxidil and finasteride.

In this case study, a 5-year-old girl with alopecia areata and atopic dermatitis that were unresponsive to previous treatments achieved substantial improvement with long-term tofacitinib, highlighting its potential safety and efficacy in managing both conditions concurrently.

This review summarizes findings on the long-term use of tofacitinib for severe alopecia areata, reporting its potential as a promising treatment option.

This study found significant differences in facial heat distribution patterns among different types of alopecia, with androgenic, areata, and telogen types showing a T-type pattern, while seborrheic alopecia showed a diffused pattern.

Minoxidil topical foam is a better, less irritating treatment for hair loss.

This study found that prototype right heart circulatory assist devices significantly improved hemodynamics and reduced pulmonary vascular resistances in piglet models of acute hemodynamic shock.

This study presents two cases correlating the clinical appearance of adult-onset foveomacular vitelliform dystrophy with optical coherence tomography findings, describing the location of the yellow vitelliform material.

This article discusses the potential benefits of using modern combination grafting techniques in hair restoration surgery, highlighting the enhanced efficiency and cosmetic coverage compared to traditional follicular unit transplantation, but presents no new clinical results.

This abstract does not provide new results; it discusses musculoskeletal disorders associated with hair transplantation surgeries and emphasizes the need for ergonomic adjustments to reduce practitioner strain.

This study developed a stable, cosmetically appealing formulation for the topical delivery of the peptide FOL-005, enhancing skin permeation and maintaining stability by keeping the peptide solid and in a water-free environment with particle sizes under 10 µm.

This article discusses the FOXTM Procedure's potential impact on hair restoration surgery, noting that its long-term effects are not yet clear and reports no new clinical findings.

This study found that the combination of oral finasteride and topical minoxidil was most effective in improving the frontal hairline in men with androgenetic alopecia.

This study concluded that 0.05% betamethasone dipropionate cream is more effective than other topical treatments for improving alopecia areata over 12 weeks.

This study found that human outer root sheath cells express VEGF receptor-2, and exogenous VEGF165 significantly stimulates their proliferation through activation of the ERK signaling pathway.

This study concluded that bundle hair grafting was an effective and safe treatment method for patients with androgenetic alopecia, providing excellent cosmetic satisfaction despite some side effects and procedural challenges.

This systematic review reports promising efficacy and safety of Tofacitinib for treating Alopecia Areata in children, though further randomized studies are needed due to the low quality of existing evidence.

CTP-543 is generally safe for treating alopecia areata.

This article discusses the concept of "donor dominance" in androgenetic alopecia, where grafted hair continues to grow in bald areas, but reports no new clinical findings.

This study assessed the impact of a New York Times article on consumer interest in androgenetic alopecia treatments by surveying dermatologists about practice trends and analyzing online search data related to low dose oral minoxidil and hair loss from February 2022 to February 2023.

This promotional content discusses hair transplant options in Jacksonville City, Arkansas, but reports no research findings; readers are encouraged to contact a specialist for more information.

In this study, researchers evaluated how subjects perceive the effectiveness of three FDA-cleared photobiomodulation devices for home use in treating androgenetic alopecia, though specific outcomes or comparative effectiveness are not reported in the abstract.

This case report describes a patient with advanced androgenetic alopecia who underwent a 6-month trial of topical minoxidil and oral finasteride, aiming to optimize hair regrowth without surgery.

In this prospective, placebo-controlled study, the researchers observed a significant reduction in hair shedding in women after applying the combined topical treatment DA-OTC-002, containing synephrine and TAAR agonists, compared to placebo, showing a 62.5% average reduction with no reported adverse events.

In a preclinical mouse model, this study found that early treatment with the selective SYK inhibitor entospletinib significantly improved survival rates and clinical outcomes for graft-versus-host disease after hematopoietic stem cell transplantation compared to placebo.